title: [Neuroleptic malignant syndrome].
authors.affiliation: Services Hospitalo-ambulatoires A, Département Universitaire de Psychiatrie Adulte DUPA, Lausanne.
authors.forename: C
authors.initials: C
authors.lastname: Bryois
authors.forename: G
authors.initials: G
authors.lastname: Bondolfi
mesh_terms: D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects; D003937:Diagnosis, Differential; D003987:Dibenzothiazepines / Q000009:adverse effects; D005260:Female; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D008297:Male; D008728:Methotrimeprazine / Q000009:adverse effects; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis* / Q000628:therapy; D011595:Psychomotor Agitation; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000523:psychology; D012307:Risk Factors
chemical_list: D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D008728:Methotrimeprazine; D006220:Haloperidol; C084602:clothiapine
vernacular_title: Le syndrome malin des neuroleptiques.